BlackBerry Runs Past Every Analyst Target as QNX Re-Rating Goes Parabolic

No Fresh Trigger, Just Momentum Feeding Itself

There is no clean news event behind this specific 19.99% leg. BB has been a one-way trade for over a week — the stock ran from $6.20 on May 20 to $10.32 by June 2, a 66% move, before tacking on more to reach $10.72. That is roughly a 73% gain in two weeks on no single discrete catalyst isolated to the move itself.

What you're watching is a re-rating that has tipped into a momentum chase. Daily RSI printed 92.62 — deep overbought territory — with the stock trading nearly 50% above its 20-day moving average and 145% above its 200-day. A golden cross in May added trend-follower fuel, and meaningful short interest means part of the rip is almost certainly covering, not fresh conviction buying. This is what a parabolic continuation looks like, not a reaction to a headline.

The QNX Story That Started It

The fundamental backdrop is real, which is why the move has legs. The base catalyst was CIBC Capital Markets raising its target to $8.50 from $6.00 with an Outperform rating, which sparked an 18% session and kicked off the run. From there the narrative did the work.

Management leaned in. At the Baird 2026 conference, CFO Tim Foote called the restructuring "complete" and framed BlackBerry as "now a growth company", pointing to QNX as a Rule of 40 business embedded in more than 275 million vehicles with growing pull in robotics and "Physical AI." On the security side, the AtHoc platform's 2026 FedRAMP Class D (High) re-certification keeps BlackBerry as the only critical event management vendor at the U.S. government's top security tier, serving roughly 80% of federal agencies. Add a renewed buyback of ~26.8 million shares, about 4.6% of float, and you have a coherent bull stack. None of it is new this week — it's been priced and re-priced for ten sessions.

Price Has Outrun the Sell Side

Here's the part traders should sit with: BB at $10.72 is trading above every published target. The Street consensus is a Hold around $4.81–$5.02 — less than half the current price — and even the freshly raised CIBC street-high of $8.50 sits more than 20% below spot. When a stock is above its most bullish analyst and double the average, the move is no longer about valuation; it's about flow and positioning.

That doesn't make it wrong — re-ratings overshoot, and the QNX optionality is genuinely hard to model — but it changes the risk. There's no analyst floor catching a pullback here, and the value score on the stock is effectively bottom-decile. Anyone long this leg is betting on momentum and the next set of targets being dragged up, not on a discount.

The Setup Into Earnings

The next hard catalyst is Q1 fiscal 2027 results on June 25. Management has guided to $132–$140 million in revenue and $0.02–$0.03 EPS, with the revenue range above the prior consensus. That print is the test: a stock this extended needs a beat-and-raise to justify spot, and anything in-line risks a sell-the-news unwind after a 70%+ run.

For the HIP-3 perp specifically, the structure cuts both ways. BB trades 24/7 on Hyperliquid via the xyz deployer, so the contract carries the equity into overnight and weekend windows when the underlying is closed — and it will gap to the cash open on any earnings or macro move. With ~$43.7 million in 24h perp volume, there's enough depth to size in, but a parabolic name into a binary event is exactly where thin overnight books and oracle gaps bite hardest.